« Return to News | Technology Solutions | Study Conduct

Biogen signs license agreement with PharmaPros

Tuesday, March 22, 2011 11:57 AM

Biogen Idec has signed a three-year enterprise license for PharmaPros' automated study management solution, Dataflow Manager. The deal includes unlimited studies and unlimited users for the duration of the license.

Biogen’s initial implementation of Dataflow Manager consists of four in-progress phase III clinical trials that spanned 36 countries, with more than 5,000 patients and 300 sites, using outsourced service providers for global monitoring and data management. Dataflow Manager provided immediate visibility into the progress of the ongoing studies, delivering real-time analytics on very large data sets including more than 300,000 forms per study, and one million lab records.

PharmaPros is a technology solutions provider specializing in data and workflow management for clinical trials.

"This is an exciting opportunity for PharmaPros, and our product. The initial implementation with Biogen allowed us to test and prove that Dataflow Manager can scale to large, complex clinical trials with very challenging study management criteria, and that both our cloud computing and SaaS delivery model work for clinical trials of any size," said Nick Neri, vice president of technology at PharmaPros.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

December 17

Medici Global says its Alzheimer's Facebook page demonstrates the need for more early detection trials

Analysts: Expect more equity purchases of CROs in 2013

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

January 2013

Parexel celebrates 30 years of change, growth
CRO's founder and chairman reflects on challenges of the past, present and future

Strategies for increasing patient diversity in trials
Sponsors look to improve racial, ethnic recruitment without going overseas

Already a subscriber?
Log in to your digital subscription.

Purchase the January issue.

Subscribe to The CenterWatch Monthly.

December 2012

Publicity, regulation tightening reins on use of KOLs
Debate rages over need to revamp how sponsors use, pay medical experts

Time may be right to makeover the investigator brochure
Size, complexity prevent critical document from being thoroughly read

Already a subscriber?
Log in to your digital subscription.

Purchase the December issue.

Subscribe to The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.